Directory · IN
Biotechnology Research in India
A register of firms and the professionals working at them in the Biotechnology Research sector based in India. Browse the public index, then filter or export on Kipplo.
Companies
3.9K on file
Vh Group
The Founder Chairman Lt. Padmashree Dr. B. V. RAO - fondly referred to as “The Father of Indian Poultry Industry”, motivated by his wife Lt. Smt. Uttaradevi Rao, established VENKATESHWARA HATCHERIES or The VH GROUP in 1971. Today the group is popularly known the world over as VENKY'S With a unique combination of expertise and supported by strategic collaborations, the company diversified into SPF eggs, chicken and eggs processing, broiler and layer breeding, genetic research and Poultry diseases diagnostic, Poultry vaccines and feed supplements, vaccine production, bio-security products, Poultry feed & equipment, nutritional health products, soyabean extract and many more. Today the group is the largest fully integrated poultry group. The VH Group plays proud mentor to a number of reputed organizations under it's umbrella and successfully caters to poultry and it's allied sectors. The pioneering efforts of the VH Group have been well recognized and rewarded with several National and International Awards. Dr. Mrs. Anuradha Desai, the Chairperson with rich experience in the poultry industry and with her dynamic and capable leadership has propelled the Group to unprecedented success in a span of 30 years. As a Chairperson of the NECC, she has played a significant role in the quantum leap of egg production, consumption & export in the country. She is the 1st woman to be elected as President of the World Poultry Science Association (IB) for 4 years in a row. The Managing Director of Uttara Foods & Feeds Pvt. Ltd, Mr. B. Venkatesh Rao has been instrumental in elevating the company to the heights it occupies today. He has by his proactive approach lifted performance of the Company to high level of efficiency and productivity, especially in operations and marketing of poultry feed. Under the leadership of Mr. B. Balaji Rao, VENKY'S has excelled in the production of SPF Eggs, processed chicken, Nutritional Health Products & Pet Healthcare Products.
10001+ staff
Aurigene Discovery Technologies
We are excited to announce that we have rebranded to AURIGENE ONCOLOGY LIMITED. Please follow and contact us on our new page:
501 to 1000 staff
Aurigene Oncology Limited
Founded in 2001, we are a clinical stage biotech company committed to bringing novel and effective therapeutics for the treatment of cancer. We leverage our deep expertise in oncology focused drug discovery and development to bring novel therapeutics to cancer patients. Since inception, we have discovered 20 novel chemical entities for clinical development. We have out-licensed several of these to pharmaceutical and biotech companies, while advancing a few on our own. We have built comprehensive drug discovery and development capabilities, nurtured a growing team of passionate scientists, and collaborated with partners across the world. For our community guidelines on LinkedIn, please visit:
201 to 500 staff
Avesthagen Limited
Avesthagen Limited - Brief Summary Avesthagen is a leading systems biology life science company uniquely positioned to help solve some of the world’s biggest healthcare and environmental challenges. Since its inception 20 years ago, Avesthagen has introduced new ideas, technologies, and products, for the life sciences market. The Avestagenome Project® is Avesthagen’s largest epidemiological study ever conducted in India, and the first such detailed system biology study worldwide on an endogamous population. The project has collected a biobank of Parsi blood samples with extensive patient data from 4,500 members and investigates the molecular basis of longevity and age-related disorders, prioritizing cancers, cardiovascular disease, diabetes and neurological disorders. Recognizing the importance of the Parsi cohort and the unique systems’ biology approach to research, the U.S-based Foundation for a Smoke-Free World, whose mission is to end smoking within this generation, recently awarded a grant to Avesthagen Limited® to prioritize research into lung and tobacco-related cancers. Avesthagen will combine liquid biopsy, next-generation sequencing (NGS), state- of-the-art bioinformatics, artificial intelligence and machine learning to identify predictive and early-stage biomarkers of cancers in smokers. The project will use non-Parsi smoker and non-smoker samples from the wider Indian and other populations to gain further insights into the evidence behind such data. Avesthagen is expected to be a key player in the lucrative personalised medicine market, which is projected to reach a value of US $1.7 trillion by 2026. Today, Avesthagen is proud to build on this heritage by partnering with others to tackle unprecedented challenges now facing our world. We believe we can provide enough healthy food for people everywhere and protect the environment for generations to come.
51 to 200 staff
Avitech Nutrition
Catering to the evolving requirements of the animal feed industry, Avitech Nutrition provides solutions backed by research and experience in the field. Apart from being a leading producer of premixes, Avitech is a provider of cutting-edge technologies in the feed additives sector. Avitech employs a large pool of scientists and has grown to become a respected and recognized corporate in the animal nutrition sector with an increasing presence in different parts of the world. Commencing operations in 1996 as a division of Indovax Pvt. Ltd, into a leading corporate today, Avitech’s journey has been characterised by innovation and customer-centricity. A premix manufacturing facility and lab were established in 2002 with the objective of providing quality premixes to the Indian feed sector. Avitech’s core competence is its experience in the animal nutrition industry and knowledge in the area of premixes and feeds additives. This provides Avitech with an in-depth view of market characteristics and enables the company to predict future trends. A highly motivated and committed team of scientists provides Avitech the ability to continuously innovate and stay at the forefront of the animal nutrition sector. Avitech’s in-house certified manufacturing facilities enable it to maintain stringent control on the quality of its products.
51 to 200 staff
Concord Biotech Limited
Concord Biotech Limited is an R&D based Biotechnology company, having focus on the fermentation, semi-synthetic and synthesis based products. Since its inception in Concord has recorded an excellent growth through diversification and process improvements. Having state-of-the-art US FDA & EUGMP approved facility; Concord is a professionally managed globally recognised supplier of fermentation based API’s and enzyme & offers services in biotechnology area like strain improvement & contract fermentation/ manufacturing. The existing portfolio of products includes API’s in the immunosuppressant, antibiotic, Oncology, Anti-Obesity, hypolipemic segments and enzymes. However, with the expertise in the field of biotechnology and chemistry, the R&D team at Concord is working towards adding new products to the product basket.
501 to 1000 staff
Gencrest
Gencrest started in November 2016. Our vision has been to make a mark into “Disruptive Technology” space. We are team of “out of the box” thinkers, scientists and engineers to “imagineer” science to provide sustainable solutions. Nature has all the solutions for everyday processes. We try to find such solutions and apply it to chemically-driven process to reduce toxic load and to provide gentle solutions for better tomorrow. We want people to experience the wonder of nature in everyday life and everywhere around them. With a state-of-the-art R&D facility, we unravel the wonders of biomolecules, called enzymes produced by tiny creatures known as microbes and mimic its processes in real world to replace chemicals used in industrial and household processes. Our expertise in biotech innovation, guided by fine-tuning of growth optimization, in-silico manipulations, recombinant designing of microbes and creation of ready-to-access superior enzymes, novel biocatalyst that disrupts the traditional global enzyme market with their advanced functioning and disruptive applications. Partner with us for innovative and disruptive solutions for cleaner and greener growth. We try to reach various sector and household care to provide gentle solutions for better tomorrow. Our company believes and supports sustainable business. Hence, this initiative looks to use green enzymes for activities that would otherwise be performed using chemicals. Nature has all the solutions for everyday processes. We try to find such solutions and apply it to chemically-driven process to reduce toxic load and to provide gentle solutions for better tomorrow. We want people to experience the wonder of nature in everyday life and everywhere around them. With a state-of-the-art R&D facility, we unravel the wonders of biomolecules, called enzymes produced by tiny creatures known as microbes and mimic its processes in real world to replace chemicals used in industrial and household processes.
201 to 500 staff
Genotypic Technology
Genotypic is now India's Genomics Technology Hub and our vision is to make it the world's Genomics Technology Hub. Look forward to your advice, help and support in achieving it. Visit Our Associate companies:Agri Genomics: Diagnostics: Genotypic is well know for simplifying complex questions into answerable bits and solving them with ease. Genotypic is SAP enabled and ISO 9001:2015 Accredited Company. AGILENT Certified Genomics Service Provider with specilization in targeted resequencing, arrays designs and large genomics projects. Genotypic is a closely held company set up in 1998. Genotypic is a profit making company, equity funded by promoters and Angel Investors. We welcome new ideas, proposals for testing early stage technologies and challenging projects -big or small- all done with the motto of simplifying Genomics. Friendly work culture, challenging projects with a mix of academic and industry experience, interaction with a chance to work on cutting edge technologies and to develop. Collaboration with leading scientists and business, opportunities to guide students, publish, present, all in one place. Genotypic's Genomics Lab includes - Ion PGM, Ion Proton, SOLiD5500xl, Nextseq500 and MiSeq; Agilent microarray platform, qPCR machines, Sanger, Molecular Biology lab and Genome informatics Unit. Genomics, NGS, Microarray, Agilent, SureSelect - Targeted resequencing, array design, Next Generation sequencing, solexa, solid, 454, helicos, Pacbio, sequence annotation, analysis, ion torrent, miseq, Nextseq500 (world's first NCBI SRA data from Nextseq500 is from Genotypic).
51 to 200 staff
Globion India Private Limited
Globion is leading manufacturer of poultry vaccines, medicines and feed additive product located in Hyderabad- a city of Poultry Strategic importance at genome valley, Biotech Park, Phase Globion intends to produce world class poultry vaccines by complying to cGMP, ISO 9001, ISO 14001 and OHSAS 18001 standards. The biotech industry has witnessed a steep growth in past decades. The accelerated growth was witnessed not in agriculture production, but also in biopharmaceutical production. This has transformed conventional methods of medication and vaccination to a new era with many novel products and its applications. Globion has commissioned a state-of-the-art Vaccine manufacturing facility complying with GMP standards. Globion produces a basket of Poultry Vaccines – Live and Inactivated -for Breeders, Layers and Broilers under. The products are marketed under the brand “GlobiVac”. Poultry Industry globally has become the most formidable source of Food Basket ensuring Food Security of World. However globalization of this industry has also thrown challenges to each major Poultry Producing Country with respect to control emerging and re emerging diseases. One of the best tool to offer this and ensuring Food safety is Research and Solution driven vaccination and disease control. Globion recognizes the need of Research and Development and is committed to invest in this segment heavily. Its R&D unit has already received recognition by Department of Science and Industrial Research, Ministry of Science & Technology, Government of India. Globion is also engaged in many futuristic product development by aligning with many local and international Research Institution.
201 to 500 staff
Jk Agri Genetics Limited
JK Agri Genetics Limited is one of the few recognized agri-input companies in India. It is mainly into the business of production, processing and marketing of high quality hybrid seeds for different crops like Bajra, Jowar, Paddy, Cotton, Maize, vegetables, etc. and micronutrients and growth promotors. The Company has acquired over 30 years of experience in this business and is proceeding further towards realizing its objective of developing seeds having superior yield potential, drought tolerance, tolerance to pests and diseases etc. Currently, the Company has production, processing and R&D facilities in Andhra Pradesh, Telangana, Karnataka, Maharashtra, Gujarat, Bihar, Tamil Nadu, Madhya Pradesh and Rajasthan, Odisha. The Company’s research mainly focuses on developing superior hybrids in different crops like cotton, maize, bajra, jowar, paddy, vegetables etc and the hybrids are marketed under the brand name of “JK Seeds”. The in-house R&D facilities located at Ranga Reddy District in Telangana are recognized by the Department of Science & Technology, Government of India and also established its state of art biotech laboratory, with facilities for tissue culture, transgenic crop development, molecular biology, molecular breeding, radio isotope laboratory, molecular QC laboratory, insectory and large containment green houses. It has achieved unique distinction of being the first Indian company commercializing Bt Cotton with indigenous GM Technology in collaboration with Indian Institute of Technology, Kharagpur. The Company has an extensive marketing network with loyal and committed distributors and dealers pan India.
201 to 500 staff
Namdhari Seeds Private Limited
Namdhari Seeds Pvt. Ltd, is one of the largest breeder, producer, distributor of quality vegetables, flower seeds and hybrid crops. It breeds and sells products in over 20 varieties of vegetable crops, with 500 commercialized hybrids across hectares of land catered by a network of 1500+ distributors, globally. It is committed to developing better yielding, disease resistant and climate-smart varieties of crops. To this end, the Company has established 20 research stations across the world for new seed development. Namdhari Seeds has worked towards building a community of millions of farmers with small land holdings by harnessing the Group’s innovative & technical skills and R&D expertise and has positively impacted the lives of millions of farmers with its products & farming programs. The Company’s success in developing market-leading, high-quality hybrids, has created a pull for its seeds within the farming community, both in India and Internationally. Today, Namdhari Seeds has a presence in over 25 countries spanning across Southeast Asia, the Middle East and Europe. With a strong brand heritage, investment in R&D, unparalleled distribution depth, vast product portfolio, Namdhari seeds has established itself as a preferred partner to several global seed players.
201 to 500 staff
Regrow Biosciences
Driven by passion, strong business ethics and commitment, Regrow Biosciences Pvt Ltd was established with a Vision to become the world's largest stem cell based tissue and organ development factory. Today, Regrow is India’s leading biotech company pioneering in the field of regenerative medicine having built a platform technology for cell based products. Regrow Biosciences has also been immensely successful in establishing premium cord blood stem cell bank; Biocell™ (formerly known as Babycell™) with patronage of more than happy parents. Our Mission remains focused to improving human healthcare by innovating and delivering regenerative medicine based solutions. Our Journey • Strong Pillars Our story began in 2009, when the experience of CEO Mr. Yash Sanghavi, Promoter of Satyan Pharmaceuticals Pvt Ltd (estd 1984) and the passion of his son, Mr. Satyen Sanghavi (Post Graduate Stem Cell Technology from University of Nottingham, UK) combined to result in creation of “Regrow”. Regrow’s RnD & GMP certified facility was set up in Lonavala (Pune) & now operates with a team of more than 30 life sciences & biotech postgraduates. • INNOVATIVEfficiency Regrow is continually cultivating an ecosystem by developing relationship with stakeholders including patients, physicians, hospitals & supply chain partners to deliver quality products targeted for diseases with unmet need. Educating the society about the benefits of “Cure vs Manage” through use of the most advanced & cutting edge medical treatments using cell therapy. Contributing to nation building by aligning the corporate strategy to Make In India. • Dream Big Aspiring to lead the cell & gene therapy sector, Regrow has successfully established technological prowess on the global platform by receiving the recognition from USFDA (United States) & EMA (Europe) for its Bone Cell Therapy product (Ossgrow®).
201 to 500 staff
Serum Institute Of India Pvt. Ltd
Serum Institute of India Pvt. Ltd. is now the world's largest vaccine manufacturer by number of doses produced and sold globally (more than 1.3 billion doses) which includes Polio vaccine as well as Diphtheria, Tetanus, Pertussis, Hib, BCG, r-Hepatitis B, Measles, Mumps and Rubella vaccines. It is estimated that about 65% of the children in the world receive at least one vaccine manufactured by Serum Institute. Vaccines manufactured by the Serum Institute are accredited by the World Health Organization, Geneva and are being used in around 170 countries across the globe in their national immunization programs, saving millions of lives throughout the world. Serum Institute of India is ranked as India's No. 1 biotechnology company, manufacturing highly specialized life saving biologicals like vaccines using cutting edge genetic and cell based technologies, antisera and other medical specialties. Serum Institute of India was founded in 1966 by Dr. Cyrus Poonawalla with the aim of manufacturing life-saving immuno-biologicals, which were in shortage in the country and imported at high prices. Thereafter, several life-saving biologicals were manufactured at prices affordable to the common man and in abundance, with the result that the country was made self-sufficient for Tetanus Anti-toxin and Anti-snake Venom serum, followed by DTP (Diphtheria, Tetanus and Pertussis) group of Vaccines and then later on MMR (Measles, Mumps and Rubella) group of vaccines. The Philanthropic philosophy of the company still not only exists but has been proliferated to bring down the prices of newer vaccines such as Hepatitis-B vaccine, Combination vaccine etc, so that not only Indian's, but the entire under-privileged children of the world are protected from birth onwards.
1001 to 5000 staff
Spinco Biotech
As a leading distributor of Analytical and Life Science Instrumentation we are committed to excellence in every function of our business - bringing people, knowledge, innovation and technology together, to provide our customers with products of the highest quality and unparalleled world class services.
501 to 1000 staff
Stemcyte India Therapeutics Pvt. Ltd
StemCyte Inc. is a world leader in cord blood banking. StemCyte India started its operations in 2010, as a joint venture between StemCyte Inc.(USA), Apollo Hospitals & Cadila Pharmaceuticals Ltd. StemCyte India is the only cord blood bank in the country that is actively involved in both Private & Public cord blood banking, clinical trials & Therapeutics Application. StemCyte India is strategically located in Apollo Hospital campus, Ahmadabad, Gujarat. It's partnership with Apollo group of Hospitals, India's leading healthcare service provider, offers a distinctive advantage to our clientele.
51 to 200 staff
The Catalysts Group
THE CATALYSTS GROUP is an expert in preventing losses for Distilling, Sugar, and Brewing Industries, being established as most trusted biotech solution providers. We provide Enzyme, Yeast & Additive-based Solutions to these industries across the globe. Our 22 years’ experience of enzyme application in Ethanol and Sugar industries have given us a distinctive edge in creating customized products. In the last 22+ years, ₹ 10,700+ ͏Crores Losses ͏Pr͏e͏v͏e͏n͏t͏e͏d 985+ Clients 23+ Countries 200+ Team Members We provide a FREE AUDIT OF PLANT / PROCESSING UNIT to identify the probable losses.# Technical Center (R&D and Production): Located in National Capital Region (Industrial hub Sahibabad, Ghaziabad, Uttar Pradesh) it is a unique facility to offer tailor-made solutions with a built-up area of sq. ft. This facility, certified by global Quality & Regulatory agencies, has a DSIR (Government of India) recognized in-house R&D Centre having a competent and qualified scientific team engaged in continual research exploration to address current and future market needs. This is an advanced application lab to replicate industrial conditions. Also, in the same premise is our manufacturing unit of MT annual capacity catering to 4 industry verticals. Entire facility is GLP & cGMP compliant and is divided into 5 blocks with state-of-the-art infrastructure for dedicated functions such as - R&D, Formulation, Fill-Finish, Warehouse, QA and QC. Our team of experienced scientists and fermentation experts provide 24*7 analytical support and troubleshooting; helping our clients improve yield, maximize productivity, and save process losses. Join our esteemed list of clients, including Radico, Dhampur, Triveni, Dalmia Group, Nirani Group, Dwarikesh Sugars, Satish Sugars, Ugar Sugars, Balrampur Chini Mills, DCM Shriram, EID Parry, Globus, India Glycol, Gulshan, Rana Group, Sula, Bira, Som Distillery and many more.
51 to 200 staff
Yashraj Biotechnology Ltd
Yashraj Biotech Limited specializes in manufacturing & supply native & recombinant antigens for the diagnostic industry, to be used in research and preparation of controls & calibrators for immunoassays. Our high-purity antigens are also used as immunogens. Our state-of-the-art manufacturing facilities in Mumbai, India, comply with ISO 13485 and ISO 9001 standards. We offer native proteins sourced from various biomedical fluids—such as cancer fluids, infected blood, pleural and ascetic fluids, seminal plasma, renal failure urine, and cerebrospinal fluid—to support the development of new biomarkers and ensure quick bulk availability. For 20 years, we have been the preferred partner of the top 20 in vitro diagnostic companies worldwide. We have expanded our global reach by establishing two subsidiaries, Germany & USA, to ensure a robust supply chain and exceptional customer service.
201 to 500 staff
Clinovo
At Clinovo, we break the operational barriers that slow clinical development. Built for sponsors who need to move faster and operate smarter, we combine embedded expertise with flexible delivery models that eliminate friction across clinical operations. With clinical trial delays costing sponsors $600K–$8M per day, our approach accelerates execution through right-fitted staff augmentation, proven FSP delivery, and AI-enhanced Digital Teammates that streamline workflow and boost productivity. Covering clinical data management, biostatistics, pharmacovigilance, and operational oversight, we deliver integrated trial support that aligns with your systems, your SOPs, and your priorities. Our teams optimize workforce models, apply real-world evidence and advanced analytics, and drive measurable impact through transparency, collaboration, and accountability. The result: faster timelines, leaner operations, and smarter decision-making—so you can bring therapies to patients sooner. Clinovo. Breaking Barriers. Faster. Leaner. Smarter.
51 to 200 staff
Histogenetics
Histogenetics is a New York-based Biotech firm which, using state-of-the-art robotics, software, and facilities, provides a suite of tissue-typing services with the highest level of quality assurance and accelerated turnaround times. We specialize in Human Leukocyte Antigen (HLA) Sequence Based Typing (SBT) services for blood cell transplants. As a pioneer in HLA sequence based typing, we have provided millions of cost-effective HLA SBT for donor registries, pharmacogenomics, donor centres, cord blood typing, transplant centres, and HLA laboratories. Apart from HLA, we also offer molecular tissue typing services for other immunologically significant genes. Our Corporate Office is located in Ossining, New York, USA. We also have a Bioinformatics and IT Development centre at Chennai, India.
51 to 200 staff
Mp Biomedicals
MP Biomedicals is dedicated to giving scientists and researchers innovative, quality tools and superior service to aid them in their quest for ground-breaking discovery and turning the hope for life-changing solutions into a reality. The company manufactures and sells more than products and is one of the only companies in the industry to offer a comprehensive line of life science, fine chemical and diagnostic products. MP Biomedicals is a world-wide corporation, with ISO-certified and FDA-approved manufacturing and distribution facilities throughout the globe and headquartered in Southern California. A vast network of global distributors and satellite facilities and offices throughout Europe, Asia, Australia and the Americas assures customers top quality products delivered when and where needed. No matter how dynamic the evolution of the life science and biotechnology markets, we remain committed to supporting our customers in their efforts to make new discoveries. From basic research, through scale-up, to full-scale production and diagnostic testing, MP Biomedicals serves every industry need – from specialized areas of research to supplying large scale quantities of fine chemicals. Our customers partner with us because they want a long-time player and reliable colleague in the fields of life science research and diagnostics. MP Biomedicals will never rest in our odyssey to remain at the forefront of discovery in the ever-changing biomedical industry.
501 to 1000 staff
Sphaera Pharma
Sphaera Pharma, founded in 2008, is an integrated drug discovery and development organization led by pharma and biotech professionals with global experience. Our goal is to bring innovative therapies to patients with unmet medical needs by developing a balanced portfolio of early stage discovery projects and clinical programs. Sphaera’s research facility in India has established in-house capabilities in ALL aspects of pre-clinical drug discovery and development. Our external alliances allow reliable access to specialized services such as in radio-chemistry, c-GMP manufacture, GLP studies, clinical formulations, structural biology and clinical development.
51 to 200 staff
4basecare
4baseCare, an Illumina-backed Company* headquartered in Singapore, is engaged in developing cutting-edge Precision Oncology Solutions using Advanced Genomics and Next-Gen digital health technology. Taking into consideration that the clinical outcome could significantly vary across different populations, we have developed a unique set of indigenous comprehensive cancer gene panels that enables oncologists to choose the optimal precision therapies for their patients. Our coveted 🧬genomic testing portfolio assesses the tumour genomic alterations by NGS from Tissue or Liquid biopsy for Somatic Mutation Analysis and Germline Mutation Testing for Hereditary and Familial Cancer from peripheral blood to personalize patient care in Oncology. 4baseCare is backed by a highly experienced Advisory board who are leaders in genomics and technology. Among them is Lip Bu Tan, Chairman of Walden International and advisor to Yali Capital, which has invested in 4baseCare. Also on the board is Francis deSouza, a Silicon Valley tech veteran and former CEO of Illumina, who brings over 30 years of expertise in genomics, technology, and healthcare. Milestones - 4baseCare’s journey has been marked by significant milestones in both funding and growth. The company has raised $6 Million in Series A funding led by Yali Capital with participation from Mathew Cyriac. In March 2021, 4baseCare had raised $2 Million in led by Mount Judi Ventures, growX ventures, Season Two Ventures, First In Ventures, and other angel investors. 4baseCare’s test has made a significant impact in Southeast Asia, with over cancer patients taking the test. 4baseCare has collaborations with more than 300 oncologists in India. This growing network with oncologists and leading hospitals in India ensures that more patients are able to opt for personalized cancer care.
51 to 200 staff
Biokart India Pvt. Ltd
At Biokart India, we are committed to assisting researchers and scientists all across India and even outside with their researches and discoveries. Our state-of-the-art genomics facility housing latest DNA and RNA analysis platforms, combined with a expert team of multidisciplinary experts strengthens our tenacity to decipher deep molecular insights.
51 to 200 staff
Biotecnika
India’s #1 Biotech Career Platform | Helping Millions Biotech & Life Science Students Upskill, Publish, Get Certified & Land Successful Jobs | BIO-IT | Bioinformatics | AI ML | CODING | CSIR NET | GATE | Career Mentorship Biotecnika Info Labs Pvt Ltd is a premier Bio-IT company specializing in Biotechnology and Information Technology. We provide cutting-edge training in Bioinformatics, AI, ML, Computational Biology, Cheminformatics, and Coding for Biologists, complemented by research-oriented project work to give students valuable hands-on experience. Recognized as the top brand for CSIR NET Life Sciences coaching, Biotecnika is the go-to platform for aspirants preparing for competitive exams like GATE, BET, ICMR, CUET, and more. Our comprehensive study materials, expert-led video tutorials, & tailored guidance ensure success. Beyond exam preparation, Biotecnika connects students with exciting job opportunities, internships, and research roles in Biotechnology, Microbiology, Bioinformatics, and Life Sciences. Join us to explore endless possibilities & advance your career in a dynamic world of biosciences! Biotecnika.org is your trusted partner in achieving your academic and professional aspirations.
11 to 50 staff
